Assessment of clopidogrel non-response by the PFA-100® system using the new test cartridge INNOVANCE® PFA P2Y

Annals of Hematology

Volumn 89, Issue 6, 2010, Pages 597-605

  Linnemann, Birgit ^a   Schwonberg, Jan ^a   Rechner, Andreas R ^b   Mani, Helen ^a   Lindhoff Last, Edelgard ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Siemens Healthcare Diagnostics Products GmbH   (Germany)

Author keywords

Antiplatelet therapy; Clopidogrel; INNOVANCE PFA P2Y; Non response; PFA 100 system

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; FIBRINOLYTIC AGENT; TICLOPIDINE;

ADULT; AGED; ANALYTIC METHOD; ARTERY CATHETERIZATION; ARTICLE; BLOOD CLOTTING TEST; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; FOLLOW UP; HUMAN; MALE; MEDICAL INSTRUMENTATION; MONOTHERAPY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; THROMBOCYTE FUNCTION; TREATMENT OUTCOME; ANALYTICAL EQUIPMENT; BLOOD; CARDIOVASCULAR SYSTEM EXAMINATION; CATHETERIZATION; CLINICAL TRIAL; DRUG EFFECT; HEMOSTASIS; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PERIPHERAL VASCULAR DISEASE; PHYSIOLOGY; PROGNOSIS; THROMBOCYTE; TREATMENT FAILURE;

AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; ASPIRIN; BLOOD PLATELETS; CATHETERIZATION, PERIPHERAL; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; FEMALE; FIBRINOLYTIC AGENTS; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; REAGENT KITS, DIAGNOSTIC; TICLOPIDINE; TREATMENT FAILURE;

EID: 77951644504     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-009-0881-9     Document Type: Article

References (39)

1. GVR Born 1962 Aggregation of blood platelets by adenosine diphosphate and its reversal Nature 194 927 929 10.1038/194927b0 1:CAS:528:DyaF38XksVGht70%3D 13871375
2. P Harrison AL Frelinger MI Furman AD Michelson 2007 Measuring antiplatelet drug effects in the laboratory Thromb Res 120 323 336 10.1016/j.thromres.2006.11.012 1:CAS:528:DC%2BD2sXmtlait74%3D 17239428 (Pubitemid 46879909)
3. KA Moffat MR Ledford-Kraemer WL Nichols CPM Hayward 2005 Variability in clinical laboratory practice in testing for disorders of platelet function. Results of two surveys of the North American specialized coagulation laboratory asscociation Thromb Haemost 93 549 553 1:CAS:528:DC%2BD2MXivVGmsLc%3D 15735808
4. JD Snoep MMC Hovens JC Eikenboom JG van der Bom JW Jukema MV Huisman 2007 Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systemic review and meta-analysis Am Heart J 154 221 231 10.1016/j.ahj.2007.04.014 1:CAS:528:DC%2BD2sXotVWrtrc%3D 17643570 (Pubitemid 47069129)
5. S Matetzky B Shenkman V Guetta M Shechter R Bienart I Goldenberg I Novikov H Pres N Savion D Varon H Hod 2004 Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction Circulation 109 3171 3175 10.1161/01.CIR.0000130846.46168. 03 1:CAS:528:DC%2BD2cXltVCgtro%3D 15184279
6. W Hochholzer D Trenk HP Bestehorn B Fischer CM Valina M Ferenc M Gick A Caputo HJ Büttner FJ Neumann 2006 Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement J Am Coll Cardiol 48 1742 1750 10.1016/j.jacc.2006.06.065 1:CAS:528:DC%2BD28XhtFOjtb7E 17084243 (Pubitemid 44648629)
7. P Buonamici R Marcucci A Migliorini GF Gensini A Santini R Paniccia G Moschi AM Gori R Abbate D Antoniucci 2007 Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis J Am Coll Cardiol 49 2312 2317 10.1016/j.jacc.2007.01.094 1:CAS:528:DC%2BD2sXmsFKmu7o%3D 17572245 (Pubitemid 46891710)
8. C Frere T Cuisset J Quilici L Camoin J Carvajal PE Morange M Lambert I Juhan-Vague JL Bonnet MC Alessi 2007 ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome Thromb Haemost 98 838 843 1:CAS:528:DC%2BD2sXht12ju7zF 17938809
9. R Marcucci R Paniccia E Antonucci S Poli AM Gori S Valente C Giglioli C Lazzeri D Prisco R Abbate GF Gensini 2007 Residual platelet reactivity is an independent predictor of myocardial injury in acute myocardial infarction patients on antiaggregant therapy Thromb Haemost 98 844 851 1:CAS:528: DC%2BD2sXht12ju73O 17938810
10. JD Snoep MM Hovens JC Eikenboom JG van der Bom MV Huisman 2007 Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events Arch Intern Med 167 1593 1599 10.1001/archinte.167.15.1593 17698681 (Pubitemid 47280339)
11. G Krasopoulos SJ Brister WS Beattie RF Elliot MR Buchanan 2008 Aspirin "resistance" and risk of cardiovascular morbidity: systemic review and meta-analysis Br Med J 336 195 198 10.1136/bmj.39430.529549.BE (Pubitemid 351212675)
12. CP Hayward P Harrison M Cattaneo TL Ortel AK Rao 2006 Platelet function analzyer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function J Thromb Haemost 4 312 319 10.1111/j.1538-7836.2006.01771.x 1:STN:280:DC%2BD28%2FjtlKntQ%3D%3D 16420557
13. B Jilma 2001 Platelet function analyzer (PFA-100®): a tool to quantify congenital or acquired platelet dysfunction J Lab Clin Med 138 152 163 10.1067/mlc.2001.117406 1:CAS:528:DC%2BD3MXntVKntL4%3D 11528368 (Pubitemid 32812228)
14. C Gachet 2005 Regulation of platelet functions by P2 receptors Annu Rev Pharmacol Toxicol 46 277 300 10.1146/annurev.pharmtox.46.120604.141207
15. J Golanski J Pluta J Baraniak C Watala 2004 Limited usefulness of the PFA-100 for the monitoring of ADP receptor antagonists-in vitro experience Clin Chem Lab Med 42 25 29 10.1515/CCLM.2004.006 1:CAS:528:DC%2BD2cXis1aktbc%3D 15061376 (Pubitemid 38401464)
16. T Mueller M Haltmayer W Poelz D Haidinger 2003 Monitoring aspirin 100 mg and clopidogrel 75 mg therapy with the PFA-100 device in patients with peripheral arterial occlusive disease Vasc Endovasc Surg 37 117 123 10.1177/153857440303700206
17. R Paniccia E Antonucci AM Gori R Marcucci C Giglioli D Antoniucci GF Gensini R Abbate D Prisco 2007 Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients J Thromb Haemost 5 1839 1847 10.1111/j.1538-7836.2007.02656.x 1:CAS:528:DC%2BD2sXhtFahtL3M 17723123 (Pubitemid 47288940)
18. J Geiger L Teichmann R Grossmann B Aktas U Steigerwald U Walter R Schinzel 2005 Monitoring of clopidogrel action: comparison of methods Clin Chem 51 957 965 10.1373/clinchem.2004.047050 1:CAS:528:DC%2BD2MXkvF2nsr0%3D 15817818 (Pubitemid 40740875)
19. H Mani B Linnemann B Luxembourg K Kirchmayr E Lindhoff-Last 2006 Response to aspirin and clopidogrel monitored with different platelet function methods Platelets 17 303 310 10.1080/09537100600746524 1:CAS:528:DC%2BD28XhtFSjtrzJ 16928602 (Pubitemid 44277696)
20. M Pidcock P Harrison 2006 Can the PFA-100 be modified to detect P2Y12 inhibition? J Thromb Haemost 4 1424 1426 10.1111/j.1538-7836.2006.01950.x 1:CAS:528:DC%2BD28XmsVGhtrY%3D 16706997
21. L Norgren WR Hiatt JA Dormandy MR Nehler KA Harris FGR Fowkes 2007 Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) Eur J Vasc Endovasc Surg 33 S1 S75 10.1016/j.ejvs.2006.09.024 17140820 (Pubitemid 46068992)
22. B Linnemann J Schwonberg H Mani S Prochnow E Lindhoff-Last 2008 Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary J Thromb Haemost 6 677 683 10.1111/j.1538-7836.2008.02891.x 1:CAS:528:DC%2BD1cXltFCqs7k%3D 18182038 (Pubitemid 351404936)
23. PA Gum K Kottke-Marchant ED Poggio H Gurm PA Welsh L Brooks SK Sapp EJ Topol 2001 Profile and prevalence of aspirin resistance in patients with cardiovascular disease Am J Cardiol 88 230 235 10.1016/S0002-9149(01)01631-9 1:CAS:528:DC%2BD3MXltlOjurc%3D 11472699 (Pubitemid 32721947)
24. GY Lip A Blann 1997 Von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 34 255 265 10.1016/S0008-6363(97)00039-4 1:CAS:528:DyaK2sXktlyitb4%3D 9205537 (Pubitemid 27241568)
25. T Chakroun G Gerotziafas F Robert C Lecrubier MM Samama M Hatmi I Elalamy 2004 In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor Br J Haematol 124 80 85 10.1046/j.1365-2141. 2003.04727.x 1:CAS:528:DC%2BD2cXkvFKmsA%3D%3D 14675411 (Pubitemid 38021626)
26. I Fuchs M Frossard A Spiel E Riedmüller AN Laggner B Jilma 2006 Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS J Thromb Haemost 4 2547 2552 10.1111/j.1538-7836.2006.02239.x 1:CAS:528:DC%2BD2sXhtFKmtA%3D%3D 17002662 (Pubitemid 44741545)
27. EH Madsen EB Schmidt N Gehr NL Johannesen SR Kristensen 2008 Testing aspirin resistance using the platelet function analyzer-100: some methodological caveats and considerations J Thromb Haemost 6 386 288 1:CAS:528: DC%2BD1cXjtVKksL4%3D 18036189
28. EJ Heilmann SK Kundu R Sio C Garcia R Gomez DJ Christie 1997 Comparison of four commercial citrate blood collection systems for platelet function detected by the PFA-100 system Thromb Res 87 159 164 10.1016/S0049-3848(97) 00115-1 1:CAS:528:DyaK2sXltVCmsro%3D 9253811 (Pubitemid 27333273)
29. PW Marshall AJ Williams RM Dixon JW Growcott S Warburton J Armstrong J Moores 1997 A comparison of the effects of aspirin on bleeding time measured using the Simplate method and closure time measured using the PFA-100, in healthy volunteers Br J Clin Pharmacol 44 151 155 10.1046/j.1365-2125.1997. 00639.x 1:CAS:528:DyaK2sXls1Wrsrc%3D 9278200
30. M Homoncik B Jilma N Hergovich P Stohlawetz S Panzer W Speiser 2000 Monitoring of aspirin (ASA) pharamcodynamics with the platelet function analyzer PFA-100 Thromb Haemost 83 316 321 1:CAS:528:DC%2BD3cXhtFWgtLk%3D 10739392
31. MCD Dalby RM Davidson JF Burman SW Davies 2000 Diurnal variation in platelet aggregation with the PFA-100 platelet analyser Platelets 11 320 324 10.1080/09537100050144731 1:CAS:528:DC%2BD3cXnvVygtb4%3D 11083456
32. YU Cho S Jang CJ Park HS Chi 2008 Variables that affect platelet function analyzer-100 (PFA-100) closure times and establishment of reference intervals in Korean adults Ann Clin Lab Sci 38 247 253 18715853
33. MT Cunningham JT Brandt WL Chandler CS Eby TE Hayes J Krishnan JB Lefkowitz JD Olson CJ Stasik J Teruya EM van Cott 2007 Quality assurance in haemostasis: the perspective from the College of American Pathologists proficiency testing program Semin Thromb Haemost 33 250 258 10.1055/s-2007- 971811 1:CAS:528:DC%2BD2sXltVKnt74%3D (Pubitemid 46581379)
34. JM Klein Gunnewiek AH Hovestad-Witterland EJ Vollaard HW Fleuren M de Metz 2005 The influence of acetylsalicylic acid intake by healthy volunteers on duplicate PFA-100 measurements Blood Coagul Fibrinolysis 16 337 340 10.1097/01.mbc.0000172099.04040.93 1:CAS:528:DC%2BD2MXltlGjurs%3D 15970717
35. J Mortensen TS Poulsen EL Grove J Refsgaard HL Nielsen SB Pedersen SS Thygesen AM Hvas SD Kristensen 2008 Monitoring aspirin therapy with the platelet function analyzer-100 Scand J Clin Lab Invest 68 786 792 10.1080/ 00365510802262680 1:CAS:528:DC%2BD1cXhsV2itbfK 18651324
36. K Andersen M Hurlen H Arnesen I Seljeflot 2002 Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease Thromb Res 108 37 42 10.1016/S0049-3848(02)00405-X 12586130 (Pubitemid 36197660)
37. B Linnemann S Prochnow H Mani J Schwonberg E Lindhoff-Last 2009 Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term follow-up Ann Hematol 88 979 988 10.1007/s00277-009-0708-8 19247655
38. M Crescente A Di Castelnuovo L Iacoviello J Vermylen C Cerletti G de Gaetano 2008 Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systemic review Thromb Haemost 99 14 26 1:CAS:528:DC%2BD1cXhtlWjurk%3D 18217130
39. JL Reny P de Moerloose M Dauzat P Fontana 2008 Use of the PFA-100® closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systemic review and meta-analysis J Thromb Haemost 6 444 450 10.1111/j.1538-7836.2008.02897.x 18194417 (Pubitemid 351280111)